4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Biomea Fusion, Inc. (BMEA) operates in the Biotechnology industry and is headquartered in San Carlos, United States with about 40 employees. Its market capitalization is roughly $93 million. In the fiscal year ended 2025-12-31, BMEA reported $0M in revenue and ($62M) in net income.
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($81M) | ($144M) | ($126M) | ($84M) | — |
| Net Income | ($62M) | ($138M) | ($117M) | ($82M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($13M) | ($12M) | ($19M) | ($21M) | ($30M) | — |
| Net Income | ($12M) | $5M | ($16M) | ($21M) | ($29M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $59M | $80M | $200M | $129M | — |
| Total Liabilities | $29M | $28M | $31M | $21M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BMEA viewer.
About TickerBase · Data methodology & sources